baber/WOPTO huggingface dataset:
Patent EP-2288391-A2 (EP)
Inventor: OTTO THOMAS
IPC: A61M60/468
Filed: 2009-04-14
Abstract: Dargestellt und beschrieben ist eine Vorrichtung (1) zur Unterstützung und/oder Übernahme der Pumpfunktion des Herzens (2), mit einem mehrschichtigen Ummantelungsteil (3) ausgebildet zur zumindest bereichsweisen Kompression des Herzens (2), wobei der Ummantelungsteil (3) wenigstens eine Stabilisierungsschicht (4) zur Formgebung des Ummantelungsteils (3) und wenigstens eine innere dehnbare Augmentationsschicht (5) aufweist und wobei zwischen der Stabilisierungsschicht (4) und der Augmentationsschicht (5) wenigstens ein mittels eines Fluides inflatierbarer und deflatierbarer Hohlraum (6) für die zyklische Kompression des Herzens (2) gebildet wird. Erfindungsgemäß ist vorgesehen, daß die Stabilisierungsschicht (4) mittels eines Fluides zumindest bereichsweise inflatierbar ist, um den Ummantelungsteil (3) von einem zusammengerollten und/oder zusammengefalteten Einführzustand beim Einfuhren der Vorrichtung in einen Körper in einen gewölbten Funktionszustand zu überführen, wobei das Herz (2) im Funktionszustand von dem Ummantelungsteil (3) zumindest teilweise ummantelt und/oder umgriffen wird.
Patent EP-2324669-A2 (EP)
Inventor: JI BAOWEI
IPC: H04W88/08
Filed: 2009-07-02
Abstract: A base station capable of wireless communication with a plurality of subscriber stations within a coverage area of a network, where the base station is capable of transmitting, to a subscriber station, a traffic indication message with an indicator value, wherein the indicator value is used by both the base station and the subscriber station to dynamically adjust the length of the next discontinuous reception (DRX) cycle in an absence of an explicit signaling message from the base station.
Patent EP-2294280-A2 (EP)
Title: Procédé de séquestration en fond de dioxyde de carbone
Inventor: RAMAKRISHNAN TERIZHANDUR
IPC: E21B43/20
Filed: 2009-07-02
Abstract: Le dioxyde de carbone est séquestré dans une formation en utilisant un procédé double de complétion et d’injection qui réduit ou supprime les taux de fuite vers le haut du dioxyde de carbone séquestré. Le procédé double de complétion et d’injection implique l’injection d’un fluide neutre tel que la saumure (eau) dans une couche perméable de la formation située au-dessus de la couche de séquestration et qui est séparée de la couche de séquestration par une couche pratiquement imperméable. L’eau est de préférence injectée en même temps que le dioxyde de carbone.
Patent EP-2318063-A2 (EP)
Title: Dispositifs médicaux ayant des revêtements formant barrière inorganiques
Inventor: SCHEUERMANN TORSTEN
IPC: A61L31/08
Filed: 2009-07-13
Abstract: L'invention porte sur des dispositifs médicaux ayant une couche barrière comprenant un matériau inorganique. Le dispositif médical a un réservoir contenant un agent thérapeutique et la couche barrière est disposée sur le réservoir. Sous un aspect, une couche barrière a une perméabilité à l'agent thérapeutique au niveau d'une partie du dispositif médical et une perméabilité différente au niveau d'une autre partie du dispositif médical. Sous un autre aspect, la quantité de dosage de l'agent thérapeutique dans le réservoir au niveau d'une partie du dispositif médical est différente de la quantité de dosage de l'agent thérapeutique dans le réservoir au niveau d'une autre partie du dispositif médical. Sous un autre aspect, une couche biorésorbable est disposée sur la couche barrière au niveau d'une ou de plusieurs parties du dispositif médical, la couche biorésorbable comprenant un matériau biorésorbable. L'invention porte également sur des procédés de revêtement d'un dispositif médical, dans lesquels une couche barrière sur un dispositif médical est formée à l'aide d'un procédé de gravure lithographique dans lequel une pluralité de particules sert de masque de gravure.
Patent EP-2317977-A2 (EP)
Title: Composition pharmaceutique présentant une force ionique relativement faible
Inventor: GHOSH MALAY
IPC: A61K9/00
Filed: 2009-08-28
Abstract: La présente invention vise à fournir des compositions pharmaceutiques, et notamment des compositions ophtalmiques multidoses. Les compositions présentent une activité antimicrobienne suffisante pour satisfaire aux exigences en matière d’efficacité de conservation aux États-Unis et/ou en Europe. Les compositions possèdent des forces ioniques relativement faibles pour contribuer à maintenir une telle efficacité.
Patent EP-2358893-A2 (EP)
Inventor: KIRCHNER FLORIAN
IPC: C07K14/32
Filed: 2009-12-15
Abstract: L'invention concerne un procédé et un moyen de production biotechnologique de riboflavine (également qualifiée ci-après de vitamine B2) par fermentation ainsi que des moyens pour mettre en oeuvre ce procédé, notamment une cellule hôte microbienne modifiée au rendement en riboflavine accru. L'invention fournit ainsi un nouveau procédé et des moyens pour réguler l'expression des activités enzymatiques participant à la production de riboflavine de la cellule hôte.
Patent EP-2346351-A2 (EP)
Inventor: PILGAONKAR PRATIBHA SUDHIR
IPC: A23L29/20
Filed: 2009-09-22
Abstract: La présente invention concerne une composition présentant un transit retardé à travers le tractus gastro-intestinal, comprenant un ou plusieurs agents actifs, de la fibre de fenugrec et au moins un excipient pharmaceutiquement acceptable. La présente invention concerne aussi des formes pharmaceutiques à rétention gastrique comprenant des fibres de fenugrec
Patent EP-2385873-A2 (EP)
Inventor: FAN LIANG-SHIH
IPC: B01D53/62
Filed: 2009-11-19
Abstract: A process for the efficient capture of CO 2  and sulfur from combustion flue gas streams and gasification based fuel gas mixtures using regenerable and recyclable calcium based sorbents. The regeneration of the calcium sorbent is accomplished by hydrating the sorbent at high temperatures of about 600° C and a pressure higher than 6 bars to lower the parasitic energy consumption.
Patent EP-2385810-A2 (EP)
Title: Iliac canal prosthesis
Inventor: RIES MICHAEL D
IPC: A61F2/28
Filed: 2009-12-02
Abstract: An acetabular prosthetic device for implantation in an iliac canal and acetabulum of an ilium comprises a stem and an acetabular component. The stem may be configured to be implanted in the iliac canal. The acetabular component may be configured to be implanted in the acetabulum and fixed to the stem. The acetabular component may further comprise a connection portion to adjustably connect the acetabular component to the stem such that the acetabular component is configured to be oriented in a plurality of orientations before being fixed to the stem.
Patent EP-2370782-A2 (EP)
Inventor: HU JINSONG
IPC: G01C22/00
Filed: 2009-12-09
Abstract: A method of operation of a navigation system having mileage mechanism includes providing a subtotal mileage for a previous location reading along a route; calculating an incremental mileage at a current location reading from the previous location reading; and calculating a total mileage based on the subtotal mileage and the incremental mileage for displaying on a device.
Patent EP-2371135-A2 (EP)
Title: Procédé et appareil de codage/décodage d'image dans un format matriciel
Inventor: JEONG YOUNG-HOON
IPC: H04N7/24
Filed: 2009-11-10
Abstract: L'invention porte sur un appareil et un procédé de codage/décodage d'une image. Le procédé consiste à générer une table de bits par mise en correspondance d'une image quantifiée, qui est quantifiée selon une profondeur de bit prédéterminée, avec une table de bits, et régler un index binaire correspondant à chaque emplacement de pixel de l'image quantifiée en référence à la table de bits; régler un index de filtre fixe correspondant à une image de chaque pixel de l'image par analyse des caractéristiques locales de l'image; générer des données en mode point par l'addition de l'index de filtre à l'index binaire; extraire un index binaire d'une table de bits et d'un index de filtre à partir des données en mode point; extraire une image codée mise en correspondance avec l'index binaire à partir de la table de bits; et filtrer l'image codée extraite sur la base d'un filtre correspondant à l'index de filtre.
Patent EP-2233811-A2 (EP)
Inventor: MAYRBAEURL ERWIN WERNER DIPL-ING
IPC: F16L9/12
Filed: 2010-03-24
Abstract: The pipe has a middle layer (1), at which reinforcement layers (2, 3) are bordered. The reinforcement layers are reinforced with short fiber e.g. glass fiber, reinforced reinforcement materials. The reinforcement layers comprise omni directional fibers and are applied in an extrusion process. The middle layer is arranged in an area of a neutral fiber, where thickness of the middle layer of the pipe comprises seventy percentage of an entire thickness of a wall of the pipe. Same or different basic polymers are utilized for the middle and reinforcement layers.
Patent EP-2213227-A2 (EP)
Inventor: WANG LI
IPC: A61N1/362
Filed: 2004-10-14
Abstract: A fluid status monitoring system for use in implantable cardiac stimulation or monitoring devices is provided for monitoring changes in thoracic fluid content. A fluid status monitor includes excitation pulse generating and control circuitry, and voltage and current measurement and control circuitry for performing a series of cardiac-gated, intra-thoracic impedance measurements. The cardiac-gated measurements are filtered or time-averaged to provide a fluid status impedance value, with respiratory noise removed. Based on comparative analysis of the fluid status impedance value, a clinically relevant trend in fluid status may be tentatively diagnosed and a fluid status response provided. Cross-check intra-thoracic impedance measurements performed using the same or a different excitation pathway and a different measurement pathway than the primary intra-thoracic impedance measurement configuration may be used to verify a tentative diagnosis.
Patent EP-2243572-A2 (EP)
Inventor: CLAASEN KARL HERMANN
IPC: B21J13/10
Filed: 2010-04-09
Abstract: The manipulator has an adjustment drive including a main shaft (3) e.g. hollow shaft, for rotatably driving a retaining tool (1) i.e. tongs. The adjustment drive has a coupling arrangement with a coupling disk (4a) that is rotatably connected with the main shaft. A coupler (4b) of the coupling disk is enclosed around the coupling disk and supported on the main shaft in a freely oscillating manner. The adjustment drive is connected with a hydraulic drive for rotatably moving the main shaft around a longitudinal axis.
Patent EP-2277733-A2 (EP)
Inventor: KLETZMAIR WALTER
IPC: B60K20/04
Filed: 2010-04-16
Abstract: The bearing has a coupler (1) attached to a lower end (2) of the bearing and to a shifting part of a gear changing drive. The coupler has a bearing lug (4) in which a ball joint is assembled with a bearing housing (6). The housing has ball cages (10) assembled with a bearing ring (9) that is sealed by caps (7, 8). A bearing pin (11) is received in the ball cages with a ball head (12), and the ball joint is retained in the bearing lug between protecting rings using the caps. Each cap is coated with non-metallic elastic yielding material (15) on two sides.
Patent EP-2292596-A2 (EP)
Inventor: SHINKAI HISASHI
IPC: C07D207/28
Filed: 1998-02-10
Abstract: The present invention provides a CETP activity inhibitor comprising as an active ingredient a compound represented by the formula (I):
     
wherein R represents a straight chain or branched alkyl group; a straight chain or branched alkenyl group; a lower haloalkyl group; a substituted orunsubstituted cycloalkyl group; a substituted or unsubstituted cycloalkenyl group; a substituted or unsubstituted cycloalkylalkyl group; a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, X 1 , X 2 , X 3 , and X, may be the same or different and each represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower haloalkyl group; a lower alkoxy group; a cyano group; a nitro group; an acyl group; or an aryl group, Y represents -CO- or -SO 2 -, and Z represents a hydrogen atom or a mercapto-protecting group, or a prodrug compound, a pharmaceutically acceptable salt, or hydrate or solvate thereof. The compounds represented by the formula (I) can increase HDL and at the same time decrease LDL through selective inhibition of CETP activity and, therefore, is expected to be useful as a new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia.
Patent EP-2306531-A2 (EP)
Inventor: HSIEH CHUNG-CHUAN
IPC: H01L33/48
Filed: 2010-04-26
Abstract: A light emitting diode is provided, including an LED chip, a reflector, a lens, a circuit plate, a circuit substrate and an electrical conductivity device. The LED chip is disposed in the reflector and the lens is disposed on the reflector, covering the reflector and the LED chip. The LED chip is electrically connected to the circuit plate. The circuit plate further includes a first through hole therein and the circuit substrate further includes a second through hole therein. The electrical conductivity device passes through the first through hole and the second through hole so that the circuit plate is electrically connect to the circuit substrate. The reflector is installed between the circuit plate and the circuit substrate. The first through hole and the second through hole are not connected to the reflector.
Patent EP-2251625-A2 (EP)
Inventor: ROBERTS MARK JULIAN
IPC: F25J1/02
Filed: 2010-05-05
Abstract: A system and method for liquefying a natural gas stream, the method including the steps of providing a dehydrated natural gas stream for liquefaction (100), pre-cooling the dehydrated natural gas stream in a pre-cooling apparatus (101), where the pre-cooling is performed by using a pre-coolant (162) that consists essentially of a hydrofluorocarbon (HFC) refrigerant, and further cooling the pre-cooled dehydrated natural gas stream (114) in a main heat exchanger (115) through indirect heat exchange against a vaporized hydrocarbon mixed refrigerant coolant (130) to produce a liquefied natural gas product stream (116), where the mixed refrigerant coolant comprises ethane, methane, nitrogen, and, preferably, less than or equal to 3 mol % of propane.
Patent EP-2209035-A2 (EP)
Inventor: MATSUSAKA KEIJI
IPC: G02B15/177
Filed: 2006-04-18
Abstract: Provided is a microminiaturized zoom optical system capable of sufficiently correcting aberration. The zoom optical system (100) includes a first lens group (101) having a negative optical power, a second lens group (102) having a positive optical power, and a third lens group (103) having a positive or negative optical power in this order from the object side. The zoom optical system is configured in such a manner that the interval between the first lens group (101) and the second lens group (102) is decreased in zooming from the wide angle end to the telephoto end. A positive lens element in the third lens group (103) or in a lens group closer to tre image side than the third lens group (103) satisfies the following conditional expression: 
ν p<40 
where vp is the minimum value of the Abbe number of the positive lens element.
Patent EP-2282175-A2 (EP)
Inventor: SUZUKI SHIN
IPC: G01D3/10
Filed: 2010-08-02
Abstract: A measurement apparatus includes a display unit, a current detection unit configured to output a detection signal if an increase in a consumption current of the display unit is detected, a plurality of setting units each of which is configured to output an output signal, each of the plurality of setting units changing the output signal if the detection signal is received, and a diagnosis unit configured to receive the output signal, the diagnosis unit diagnosing the increase in the consumption current.
Patent EP-2261356-A2 (EP)
Inventor: FRASER CLAIRE
IPC: C12R1/36
Filed: 1999-04-30
Abstract: The invention provides proteins from Neisseria mcningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.
Patent EP-2292275-A2 (EP)
Inventor: ROBERTS JOSEPH
IPC: A61K48/00
Filed: 2001-10-11
Abstract: The present invention relates to a method for determining the modification conditions of a therapeutic agent comprising (1) assaying the biological activity of a first modified therapeutic agent after the first modified therapeutic agent has been administered to a subject; (2) assaying the biological activity of the first modified therapeutic agent after at least one booster dose of the first modified therapeutic agent has been administered to said subject (3) carrying out (1) and (2) with an additional modified therapeutic agent that has been modified differently than the first modified therapeutic agent, and (4) comparing the biological activity of the first modified therapeutic agent with the biological activity of the additional modified therapeutic agent. The present invention also relates to modified therapeutic agents.
Patent EP-2314294-A2 (EP)
Inventor: BJELDANES LEONARD F
IPC: A61K31/404
Filed: 2005-11-04
Abstract: The invention provides immune response activating compositions and methods of use. The general methods deliver an immune response activator to a patient determined to be in need thereof, comprising the steps of: (a) administering to the patient a predetermined amount of an immune response activating, optionally substituted DIM; and (b) detecting in the patient a resultant immune response activation, such as an increase in T-cell proliferation, NO production, cytokine production, cytokine receptor expression, or cytokine signaling.
Patent EP-2336561-A2 (EP)
Inventor: DAVIS JOHN P
IPC: F03D1/00
Filed: 2010-12-09
Abstract: A modular life extension kit (300) for use with a support frame (46) for a wind turbine generator (34), the support frame including at least a support member (56) coupled to a support cross-member (58,59), the support member having a first length (62) and the support cross-member having a second length is provided. The modular life extension kit includes a plurality of plates (301,302,304,306,308,310,312) configured to be coupled to the support frame, wherein at least a first plate of the plurality of plates has a first side (314) configured to be coupled to the support member and a second side (316) configured to be coupled to the support cross-member, the first side extending at least five percent of the first length and the second side extending at least five percent of the second length.
Patent EP-2233264-A2 (EP)
Inventor: HAYASHI SEIICHIRO
IPC: B29C48/11
Filed: 2010-03-26
Abstract: There is described a die for (1) forming a honeycomb structure, comprising a platy die base member having a clay supply face (8) on one end to which a plurality of introduction holes (4) for introducing a mixed material containing ceramics are formed; a clay forming face (7) to which a plurality of slits (5) connected to the introduction holes (4) is formed on the other end face in lattice-like partition regions, and from which the clay is extruded to form a formed honeycomb article, at least a part of lattice-like partition regions defined by the slits being provided in such a position that the extended line of said at least part of a plurality of lattice-like regions overlap with the slits along the edges of the regions in a plane seen from a thickness direction (201) of the die base member, inner peripheral slits (50) formed in the inner peripheral region (22) of the clay forming face (7) and having a predetermined slit width, and outer peripheral slits (53) formed in the outer peripheral region (24) surrounding the periphery of the inner peripheral region and having a width-enlarged portion (52) having a width larger than that of the inner peripheral slit.
Patent EP-2348451-A2 (EP)
Inventor: HAZRA MOUSUMI
IPC: G06F21/88
Filed: 2010-10-29
Abstract: A method for accessing a platform with an anti-theft (AT) mechanism, comprising initiating entry to a standby state by sending a platform public key to a server; receiving a server public key; receiving an encrypted and signed AT permit; sending a rendezvous message to the server; receiving an encrypted and signed AT standby transition message from the server; validating the standby transition message; sending an RSA signed acknowledgement to the server; and entering the standby state on the platform.
Patent EP-2410989-A2 (EP)
Title: Liposomes réducteurs du taux de cholestérol
Inventor: POLLOCK STEPHANIE
IPC: A61K9/127
Filed: 2010-03-26
Abstract: Cette invention concerne des procédés permettant de réduire le taux de cholestérol cellulaire en utilisant des particules lipidiques capables de pénétrer dans les cellules. Ces particules lipidiques peuvent être utilisées pour traiter ou prévenir une maladie ou une pathologie causée par un accroissement du taux de cholestérol cellulaire ou associée à cela, et pour traiter ou prévenir une maladie ou une pathologie qui est causée par un virus dont la réplication dépend du cholestérol cellulaire ou associée celui-ci.
Patent EP-2445431-A2 (EP)
Inventor: GEIST WYATT DRAKE
IPC: A61B17/88
Filed: 2010-06-25
Abstract: A surgical guide wire or K-wire and method of use are provided. The K-wire or guide wire has opposite end portions and a shank portion in between. One end portion has a deformable end portion that, once outside of a confining guide passage, can be deformed to present a projected forward facing area that is larger than the transverse cross section of the K-wire or guide wire while in the passage. The increased area will provide increased resistance to additional forward axial movement into the surgical site.
Patent EP-2480654-A2 (EP)
Inventor: PAULLIER PATRICK
IPC: B81B1/00
Filed: 2010-09-23
Abstract: The invention relates to a filtration device (100), characterized in that it includes: a first block (101) having a cavity forming a first chamber (110) comprising a bottom wall (111) having a set of microstructures including micro-walls and micro-contacts, the set of microstructures defining micro-chambers and micro-channels on the bottom wall (111) of the culture chamber; a second block (102) having a cavity forming a second chamber (120); and a filtration membrane (130), the first block (101), the membrane (130), and the second block (102) being arranged such that the membrane (130) is located between the first chamber (110) and the second chamber (120), adjacent to each of the first and second chambers (110, 120); as well as a first opening and a second opening for enabling a first fluid to pass into the second chamber (120) which is separated from the first chamber (110) by the membrane (130).
Patent EP-2477792-A2 (EP)
Title: Appareil robotique mettant en  oeuvre un mécanisme anticollision et procédés associés
Inventor: BOSSCHER PAUL MICHAEL
IPC: B25J9/16
Filed: 2010-09-16
Abstract: L'invention concerne un système robotique qui met en œuvre un mécanisme anticollision et qui comprend un premier manipulateur robotique et un premier contrôleur configuré pour contrôler le premier manipulateur robotique pour un mouvement le long d'une première trajectoire réelle prédéfinie. Un second contrôleur est configuré pour contrôler le mouvement d'un second manipulateur robotique pour un mouvement le long d'une seconde trajectoire prévue prédéfinie et dévier à partir de celle-ci pour se déplacer dans une trajectoire d'esquive loin de la première trajectoire réelle prédéfinie sur la base de la détermination d'une collision potentielle avec le premier manipulateur robotique sans connaissance préalable de la première trajectoire réelle prédéfinie.